Weiner: In the last
twenty years, China has transformed to a very rapidly developing country. So,
there's more and more older people living in China and I've seen some data that
suggests the number of patients with Alzheimer's/dementia in China right now
exceeds the number in the United States. Well, it's much, much bigger country,
but the rate of growth of Alzheimer's patients in China is very, very rapid now.
Narrator: Weiner is the principal investigator of a nationwide, sixty-center effort to find early biomarkers of the disease. It's called the Alzheimer's Disease Neuroimaging Initiative, or ADNI and Weiner says, now China is interested in following their successful model. For Science Today, I'm Larissa Branin.